Body Text
Competitive advantage
- Novel synthetic materials with user-defined dynamics enable spatiotemporal control over cell assembly and activity
- Expertise in the precise control of chemistry and mechanics in vitro to homogenise cell state for the tuning of a desired population
- Skills at controlling and directing cell state in the laboratory facilitate 3D assembly into functional tissue-mimetic architectures
Impact
- Coatings and materials for reproducible manufacture of clinically useful cells from donor banks or patients
- Model systems comprised of 2D/3D spheroids and organoids for development and disease modelling, and for drug development
Successful outcomes
- Engineering melanoma heterogeneity in a microtumour array for testing combination therapies
- Multicellular heterotypic models of tissue microenvironments with 3D printed vasculature
Capabilities and facilities
- GeneTech-approved PC2 laboratory with lithographic, ink jet and direct-write printing
- Wet chemistry and molecular biology laboratories
Our partners
- Mayo Clinic
- Cynata Therapeutics